Zain S Hussain

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Researcher

UAMS

Also affiliated: Texas Tech University (2020–2022); Scottish Agricultural Science Agency (2025); Oregon Health & Science University (2021); Cornell University (2023); University of Medicine and Health Sciences (2023–2025); Ross University School of Veterinary Medicine (2022–2026); Methodist Hospital (2023); Dean McGee Eye Institute (2022–2026); Arkansas Department of Agriculture (2025); University of Oklahoma Health Sciences Center (2023–2025); New York University (2024–2025); University of Portland (2021); University of Glasgow (2024–2025); University of Oklahoma (2022–2023); Texas Tech University Health Sciences Center (2020–2022)

Faculty Researcher

7 h-index 39 pubs 152 cited

Research Areas

Biomedical Subjects

OverviewAI-generated summary

Zain S Hussain's research focuses on the intersection of metabolic disorders, particularly type 2 diabetes, and ocular health. His work investigates the influence of various medications and patient characteristics on the progression of diabetic complications such as diabetic macular edema. Hussain has also examined the comparative effects of different classes of diabetes medications, specifically GLP-1 receptor agonists and metformin, on the risk of developing glaucoma in patients with type 2 diabetes. His research extends to understanding the surgical management of glaucoma, analyzing trends in glaucoma surgery among Medicare beneficiaries following reimbursement changes. Additionally, Hussain has contributed to the study of retinoblastoma, investigating the impact of tumor laterality on patient survival using retrospective data. His scholarly output includes 40 publications with 187 citations and an h-index of 7. He has collaborated with several researchers at the University of Arkansas for Medical Sciences, including Muhammad Z. Chauhan (7 shared publications), Ahmed F. Shakarchi (3 shared publications), and Dane A. Jester (2 shared publications).

Metrics

h-index: 7
Publications: 39
Citations: 152

Selected Publications

Systemic Anemia and the Risk of Diabetic Macular Edema and Anti-VEGF Injections (2026)

Ophthalmology Retina DOI OpenAlex
Pars Plana Vitrectomy, Glycemic Control, and Systemic Adverse Events in Patients With Diabetes Mellitus: A Retrospective Cohort Study (2026)

Research Square DOI OpenAlex
Reply (2026)

Journal of the American College of Radiology DOI OpenAlex
The Influence of Smoking, Cessation Measures, and Other Substances on Progression of Diabetic Retinopathy in Type 2 Diabetes (2025)

Ophthalmic surgery, lasers & imaging retina DOI OpenAlex
Nationwide Analysis of Progressive Kidney Function Decline and Diabetic Macular Edema in Type 2 Diabetes (2025)

Ophthalmology Science 2 citations DOI OpenAlex
Reply to Comment on: “Is There a Safe Glycemic Threshold for Cataract Surgery?” (2025)

American Journal of Ophthalmology DOI OpenAlex
Potency Matters: The Role of Statin Intensity in Modulating Risk for Age-Related Macular Degeneration (2025)

American Journal of Ophthalmology 7 citations DOI OpenAlex
Risk of Systemic Health Events and Mortality After Vitrectomy for Diabetic Retinopathy in Patients with Type 2 Diabetes (2025)

Ophthalmology Science DOI OpenAlex
Risk of Giant Cell Arteritis among Patients Presenting with Undifferentiated Noninfectious Uveitis (2025)

Ophthalmology 2 citations DOI OpenAlex
Is There a Safe Glycemic Threshold for Cataract Surgery? (2025)

American Journal of Ophthalmology 7 citations DOI OpenAlex
Performance of DeepSeek, Qwen 2.5 MAX, and ChatGPT Assisting in Diagnosis of Corneal Eye Diseases, Glaucoma, and Neuro-Ophthalmology Diseases Based on Clinical Case Reports (2025)

medRxiv 16 citations DOI OpenAlex
Re: Hsu et al.: Risk of uveitis among e-cigarette users: a multi-institutional TriNetX study (Ophthalmology. 2025;132:370-373) (2025)

Ophthalmology 2 citations DOI OpenAlex